Zimmer Biomet Holdings ZBH EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Zimmer Biomet Holdings’s reported figures.
Based on trailing twelve months.
The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zimmer Biomet Holdings's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zimmer Biomet Holdings's EBITDA margin?
- Zimmer Biomet Holdings (ZBH) reported EBITDA margin of 27.2% in Q1 2026.
- How has Zimmer Biomet Holdings's EBITDA margin changed year-over-year?
- Zimmer Biomet Holdings's EBITDA margin decreased by 9.9% year-over-year, from 30.2% to 27.2%.
- What is the long-term trend for Zimmer Biomet Holdings's EBITDA margin?
- Over 4 years (2021 to 2025), Zimmer Biomet Holdings's EBITDA margin has grown at a 2.2% compound annual growth rate (CAGR), from 106.4% to 116.2%.
- What does EBITDA margin mean?
- Operating cash profitability per sales dollar, before interest, taxes, and non-cash charges.
- How do you interpret EBITDA margin?
- Useful for comparing operating profitability across firms with different depreciation policies and leverage. High EBITDA margin alongside heavy capex can still mean weak free cash flow — pair it with FCF margin.
- How does EBITDA margin compare across companies?
- Widely used to compare capital-intensive businesses on a like-for-like basis. Less meaningful for banks and insurers.